Published in Hematol Oncol Stem Cell Ther on January 01, 2011
Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5). Blood (2012) 1.82
Role of phosphatidylinositol 3'-kinase/AKT pathway in diffuse large B-cell lymphoma survival. Blood (2006) 1.70
Clinical characteristics and treatment outcome of pediatric patients with chronic myeloid leukemia. Haematologica (2010) 1.53
Human herpesvirus 7 in pediatric hematopoietic stem cell transplantation. Pediatr Blood Cancer (2007) 1.46
Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors. Blood (2010) 1.33
Umbilical cord blood transplantation for children with thalassemia and sickle cell disease. Biol Blood Marrow Transplant (2011) 1.24
Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience. Blood (2013) 1.21
Child health and survival in the Eastern Mediterranean region. BMJ (2006) 1.11
Clinical characteristics and outcome of children with biphenotypic acute leukemia. Haematologica (2009) 1.07
Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita. Biol Blood Marrow Transplant (2013) 1.07
Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood? Blood (2012) 1.07
Localised Ewing sarcoma/PNET of bone--prognostic factors and international data comparison. Med Pediatr Oncol (2002) 1.05
Ocular findings after allogeneic hematopoietic stem cell transplantation. Ophthalmology (2009) 1.04
The Saudi experience in fludarabine-based conditioning regimens in patients with Fanconi anemia undergoing stem cell transplantation: excellent outcome in recipients of matched related stem cells but not in recipients of unrelated cord blood stem cells. Biol Blood Marrow Transplant (2011) 0.92
Dexamethasone-associated toxicity during induction chemotherapy for childhood acute lymphoblastic leukemia is augmented by concurrent use of daunomycin. Cancer (2003) 0.91
Prevalence of fragile histidine triad expression in tumors from saudi arabia: a tissue microarray analysis. Cancer Epidemiol Biomarkers Prev (2006) 0.88
Outcome and toxicity of chemotherapy for acute lymphoblastic leukemia in children with Down syndrome. Pediatr Blood Cancer (2009) 0.87
Long-term survival and late deaths after hematopoietic cell transplantation for primary immunodeficiency diseases and inborn errors of metabolism. Biol Blood Marrow Transplant (2012) 0.84
Outcome of aplastic anaemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant. Br J Haematol (2015) 0.84
Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East. Ann Hematol (2007) 0.83
Second stem cell transplantation in patients with Fanconi anemia using antithymocyte globulin alone for conditioning. Biol Blood Marrow Transplant (2008) 0.82
Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency. Biol Blood Marrow Transplant (2010) 0.81
Pediatric lymphoma: a 10-year experience at a tertiary care hospital in Pakistan. J Pediatr Hematol Oncol (2010) 0.80
Vincristine-itraconazole interaction: cause for increasing concern. J Pediatr Hematol Oncol (2002) 0.80
Trends of hematopoietic stem cell transplantation in the Eastern Mediterranean region, 1984-2007. Biol Blood Marrow Transplant (2011) 0.80
Cytomegalovirus retinitis in children and young adults with acute lymphoblastic leukemia in Lebanon. Leuk Lymphoma (2014) 0.80
HLA-matched sibling transplantation for severe aplastic anemia: impact of HLA DR15 antigen status on engraftment, graft-versus-host disease, and overall survival. Biol Blood Marrow Transplant (2012) 0.79
Efficacy of vincristine and carboplatin as chemo-reduction for advanced bilateral retinoblastoma, the Saudi experience. Saudi J Ophthalmol (2013) 0.79
A novel HAX1 gene mutation in severe congenital neutropenia (SCN) associated with neurological manifestations. Eur J Pediatr (2010) 0.79
Outcome of pediatric patients with lymphoma following stem cell transplant: a single institution report. Leuk Lymphoma (2014) 0.78
Invasive chaetomium infection in two immunocompromised pediatric patients. Pediatr Infect Dis J (2007) 0.78
Outcome of second allogenic stem cell transplantation in pediatric patients with non-malignant hematological and immune deficiency disorders. Pediatr Blood Cancer (2010) 0.77
Allogeneic hematopoietic stem cell transplantation in leukocyte adhesion deficiency type 1: a single center experience. Biol Blood Marrow Transplant (2011) 0.77
Outcome of Ewing sarcoma in a multidisciplinary setting in Lebanon. Pediatr Blood Cancer (2014) 0.77
Status of hematopoietic stem cell transplantation in the WHO Eastern Mediterranean Region (EMRO). Transfus Apher Sci (2010) 0.76
Epstein-Barr virus infection is not the sole cause of high prevalence for Hodgkin's lymphoma in Saudi Arabia. Leuk Lymphoma (2006) 0.76
Does adding ATG to the GVHD prophylaxis regimen help reduce its incidence? Bone Marrow Transplant (2003) 0.75
Idiopathic colonic calcification: a case report. Ger Med Sci (2013) 0.75
Cyclophosphamide and topotecan as first-line salvage therapy in patients with relapsed ewing sarcoma at a single institution. J Pediatr Hematol Oncol (2013) 0.75
In cyclosporine induced neurotoxicity, is tacrolimus an appropriate substitute or is it out of the frying pan and into the fire? Pediatr Blood Cancer (2008) 0.75
Factors Determining the Outcome of Hematopoietic Stem Cell Transplantation in Patients With Acute Lymphoblastic Leukemia at King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. J Pediatr Hematol Oncol (2016) 0.75
High throughput tissue microarray analysis of FHIT expression in diffuse large cell B-cell lymphoma from Saudi Arabia. Mod Pathol (2006) 0.75
Cytomegalovirus infections in unrelated cord blood transplantation in pediatric patients: incidence, risk factors, and outcomes. Hematol Oncol Stem Cell Ther (2011) 0.75
Successful outcome in two patients with CD40 deficiency treated with allogeneic HCST. Clin Immunol (2012) 0.75
Improved outcome for children with acute lymphoblastic leukemia after risk-adjusted intensive therapy: a single-institution experience. Ann Saudi Med (2008) 0.75
Intra-leukocytic hemosiderin inclusions detected as pseudoeosinophils by automated depolarization analysis in a patient with beta-thalassaemia major and immune hemolysis. Blood Cells Mol Dis (2005) 0.75
Outcome of risk adapted therapy for relapsed/refractory acute lymphoblastic leukemia in children. Leuk Lymphoma (2012) 0.75
Development and implementation of a distributed integrated data-management system for pediatric hematology/oncology service: a modular approach for a clinical outcome and research information system. J Registry Manag (2012) 0.75
The outcome of children with acute myeloid leukemia (AML) post-allogeneic stem cell transplantation (SCT) is not improved by the addition of etoposide to the conditioning regimen. Pediatr Blood Cancer (2006) 0.75